Witnessing the stock’s movement on the chart, on February 11, 2021, Aprea Therapeutics Inc. (NASDAQ: APRE) had a quiet start as it plunged -9.82% to $7.35. During the day, the stock rose to $8.46 and sunk to $7.33 before settling in for the price of $8.15 at the close. Taking a more long-term approach, APRE posted a 52-week range of $4.66-$41.12.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -64.90%. This publicly-traded company’s shares outstanding now amounts to $21.19 million, simultaneously with a float of $18.45 million. The organization now has a market capitalization sitting at $149.43 million. At the time of writing, stock’s 50-day Moving Average stood at $13.46, while the 200-day Moving Average is $24.54.
Aprea Therapeutics Inc. (APRE) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Aprea Therapeutics Inc.’s current insider ownership accounts for 12.91%, in contrast to 88.70% institutional ownership. According to the most recent insider trade that took place on Oct 05, this organization’s Former 10% holder sold 175,000 shares at the rate of 25.30, making the entire transaction reach 4,427,500 in total value, affecting insider ownership by 138,497. Preceding that transaction, on Jul 07, Company’s 10% Owner sold 241,703 for 34.55, making the whole transaction’s value amount to 8,350,839. This particular insider is now the holder of 1,992,586 in total.
Aprea Therapeutics Inc. (APRE) Earnings and Revenue Records
As on 9/29/2020, Multinational firm has announced its last quarter scores, in which it reported -$0.58 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.76) by $0.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
Aprea Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -64.90% and is forecasted to reach -1.94 in the upcoming year.
Aprea Therapeutics Inc. (NASDAQ: APRE) Trading Performance Indicators
Let’s observe the current performance indicators for Aprea Therapeutics Inc. (APRE). It’s Quick Ratio in the last reported quarter now stands at 7.50. The Stock has managed to achieve an average true range (ATR) of 0.57.
In the same vein, APRE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.30, a figure that is expected to reach -0.64 in the next quarter, and analysts are predicting that it will be -1.94 at the market close of one year from today.
Technical Analysis of Aprea Therapeutics Inc. (APRE)
Going through the that latest performance of [Aprea Therapeutics Inc., APRE]. Its last 5-days volume of 2.5 million indicated improvement to the volume of 2.22 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 80.79% While, its Average True Range was 0.75.
Raw Stochastic average of Aprea Therapeutics Inc. (APRE) in the period of the previous 100 days is set at 10.22%, which indicates a major fall in contrast to 66.77% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 90.59% that was lower than 265.38% volatility it exhibited in the past 100-days period.